Fact CheckerSign in

NCT07803042Not yet recruiting

Using a Digital Spacer for Inhaler Technique Education in Pediatric Asthma

Using the Aflo™ Digital Smart Spacer Platform to Improve Inhaler Technique in Children With Uncontrolled Asthma: A Prospective Pilot Study - INSPIRE-KIDS (INhaler SPacer Improvement & Real-time Education - KIDS)

Source: ClinicalTrials.gov · Last updated 3 Sept 2026

Brief summary (registry, in English)

This pilot study evaluates the feasibility, usability, and potential effect of the aflo™ Smart Spacer platform in children aged 6-18 with uncontrolled asthma using pMDIs and spacers. The study investigates changes in inhaler technique, asthma control, and lung function following 3 months of daily use of the CE-marked aflo™ device.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
12 (estimated)
First submitted
25 Aug 2026
Start date
Sept 2026
Primary completion date
Jan 2027
Lead sponsor
University Medical Center Groningen
Diseases
Asthma
NCT number
NCT07803042

What you commit to

  • Study type: Interventional
  • Planned participants: 12
  • From Sept 2026 to the primary completion date, Jan 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Chronic lung disease other than asthma
  • Significant cardiac disease

Other

  • Not able to understand Dutch sufficiently
  • No access to stable mobile internet

Who the study is looking for

  • Age 6-18 years
  • Physician-diagnosed asthma
  • Using ICS ± LABA ± LAMA ± SABA via pMDI and spacer suitable for aflo™
  • Uncontrolled asthma (ACT \<19 and/or recent exacerbation and/or suspected nonadherence/poor technique)
  • Access to an Apple or Android smartphone (OS ≥ 4.3)
  • Willing and able to give assent/consent (parents/guardians for minors)

Age in the registry: 6 years to 18 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
UMC Groningen
Coordinator of this site? Confirm its status
GroningenNetherlandsUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.